topic

250 Manipulating T cell epigenetic programs to improve persistence against group 3 pediatric medulloblastoma
Meghan W Dukes, Linda Senaoui, Haley Houke, Frederique Zindy, Benjamin Youngblood, Martine Roussel, Giedre Krenciute

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A289; DOI: 10.1136/jitc-2023-SITC2023.0250
251 Targeting HLA-G positive tumors with engineered Natural Killer cells expressing a Chimeric ILT Receptor (CIR)
MyLinh Duong, Jihyun Park, Raphael Ognar, Simon Wain-Hobson, Henri Bayle

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A290; DOI: 10.1136/jitc-2023-SITC2023.0251
252 The combination of ACT and INDUKINE therapy leads to improved antitumor immunity in solid tumors
Connor J Dwyer, Heather R Brodkin, Olivia G Donovan, Kyriakos Economides, Daniel J Hicklin, Julie LePrevost, Kristin Morris, Cynthia Seidel-Dugan, William M Winston, Andres Salmeron

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A291; DOI: 10.1136/jitc-2023-SITC2023.0252
253 Cell avidity drives the functional responses of immunotherapies with superior correlates to in vivo performance
Jens Eberlein, Justin Moser, Song-My Hoang, Luis Acero, Zhou Zhong, Russell Mellen, Keith Bailey, Will Singleterry, Andrea Candelli

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A292; DOI: 10.1136/jitc-2023-SITC2023.0253
254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer
Piril Erler, Hana Cho, Jordan Skinner, Laurent Poirot, Beatriz Aranda-Orgilles

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A293; DOI: 10.1136/jitc-2023-SITC2023.0254
255 Functional and multi-omic characterization of CAR T cells across healthy donors
Daniel Fil, Lora J Rogers, Brian Koss, Michael A Bauer

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A294; DOI: 10.1136/jitc-2023-SITC2023.0255
256 Dual-targeted CAR T cells boost antitumor immunity against solid tumors
Amanda Finck, Ziming Wang, Ugur Uslu, Sofia Castelli, Andrew Rech, Julianna Latini, Donna Gonzalez, Tong Da, Regina M Young, Carl H June

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A295; DOI: 10.1136/jitc-2023-SITC2023.0256
257 NOT gate gene circuits expand the range of tumor-associated antigens addressable by CAR-NK and -T cell therapies
Nicholas W Frankel, Assen Roguev, Marcus Gainer, Ippolito I Caradonna, Tony Hua, Han Deng, Gozde Yucel, Alice Lam, Yongshuai Li, Michelle Hung, Derrick Lee, Chen-Ting Lee, Andrew Banicki, Mengxi Tian, Niran Almudhfar, Lawrence Naitmazi, Russell M Gordley, Brian Garrison, Kanya Rajangam, Timothy K Lu

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A296; DOI: 10.1136/jitc-2023-SITC2023.0257
258 Enhancing tumor infiltration of CAR T cells in solid tumors
Giovanni Galletti, Miguel Reina Campos, Maximilian Heeg, Mikael Sigvardsson, Ananda Goldrath

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A297; DOI: 10.1136/jitc-2023-SITC2023.0258
259 Discovery of synthetic signaling pathway receptors that increase the potency of CAR-T cells through optimized STAT activity
Thomas J Gardner, Beatriz Millare, Anzhi Yao, Lan Chen, Ashley Cass, Suchismita Mohanty, Jeremy Chen, Alma Gomez, David DeTomaso, Manching Ku, Lionel Berthoin, Meng Lim, Azalea Ong, Vince Thomas, Nicholas Quant, Brian Hsu, Amy-Jo Casbon, Natalie Bezman, Aaron Cooper, Levi Gray-Rupp, Angela Boroughs, W Nicholas Haining

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A298; DOI: 10.1136/jitc-2023-SITC2023.0259

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages